| Trial ID: | L6808 |
| Source ID: | NCT01392898
|
| Associated Drug: |
Liraglutide
|
| Title: |
Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes
|
| Acronym: |
ELEGANT
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: liraglutide|DRUG: Insulin
|
| Outcome Measures: |
Primary: Body weight change (measured body weight at 26 weeks minus baseline body weight), Measuring body weight after 26 weeks minus baseline body weight as the change in body weight after Liraglutide treatment., 26 weeks (26 weeks - baseline) | Secondary: Measuring change in insulin dose (insulin dose at 26 weeks minus insulin dose at baseline), Change in insulin dose by measuring insulin dose at 26 weeks minus the insulin dose at baseline., 26 weeks (26 weeks -baseline)
|
| Sponsor/Collaborators: |
Sponsor: Radboud University Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2012-02
|
| Completion Date: |
2014-05
|
| Results First Posted: |
|
| Last Update Posted: |
2013-08-02
|
| Locations: |
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
|
| URL: |
https://clinicaltrials.gov/show/NCT01392898
|
